Infectious Diseases Society of America (IDSA - IDWEEK), 2019

• Infectious Diseases Society of America (IDSA - IDWEEK), 2019
• du 02/10/2019 au 06/10/2019
• Washington, USA

Posters

Denosumab related osteonecrosis of the jaw: an emergent and potentially complex bone and joint infection

• Bricca R
• Valour F
• Conrad A
• Braun E
• Jaby P
• Bachelet T
• Breton P
• Gleizal A
• Laurent F
• Chidiac C
• Ferry T
• on behalf of Lyon BJI Study Group

Comparison of tolerance and microbiological efficacy of cefepim and piperacillin/tazobactam in combination with vancomycin as empirical antimicrobial therapy of prosthetic joint infection: a propensity-matched cohort study

• Triffault-Fillit C
• Mabrut E
• Corbin K
• Becker A
• Braun E
• Tod M
• Goutelle S
• Fessy M
• Dupieux C
• Laurent F
• Lustig S
• Chidiac C
• Ferry T
• on behalf of Lyon BJI Study Group

Purified personalized bacteriophages as part of salvage therapy in patients with complex BJI: A 2-year experience in a reference center in France

• Ferry T
• Kolenda C
• Leboucher G
• Batailler C
• Fevre C
• Lustig S
• Laurent F
• on behalf of Lyon BJI Study Group

Impact on the gut microbiota of the prolonged antimicrobial therapy in patients with bone and joint infection (BJI): results from the OSIRIS prospective study in France

• Levast B
• Batailler C
• Boucihna L
• Le Camus C
• Lustig S
• Pouderoux C
• Boutoille D
• Dauchy FA
• Zeller V
• Senneville E
• Maynard CM
• Mialon A
• Laurent F
• Ferry T
• on behalf of Lyon BJI Study Group